NATCO Pharma Ltd was incorporated in Hyderabad in 1981 with an initial investment of about US$ 54,954. With a modest beginning of operations as a single unit with 20 employees, NATCO today has five manufacturing facilities spread across India with dedicated modern research laboratories, capabilities in new drug development, etc.
NATCO currently consists of more than 2,500 employees, and is consistently ranked among the fastest growing pharmaceutical companies in India. It is well recognised for its innovation in pharmaceutical research and development (R&D).NATCO is utilising its collective professional experience to kickstart its transformation into a major player in the global pharmaceutical industry. NATCO has at present, 66 Indian and international granted patents. Furthermore, it has filed for 41 Indian and 85 international applications.
In addition, NATCO also exports its finished products to countries in North America, Europe, South America, Middle East and Southeast Asia.
Natco Pharma: High-quality Generic Drugs Producers
|2011||Forms joint venture (JV) company with Levomed LLC, USA for sales and distribution in Brazil|
|2009||Inaugurates NATCO Organics at Chennai, India, with facilities dedicated for cyto-toxic APIs and biotechnology products|
|2008||Files its first Paragraph IV filing in the US market|
|2006||Inaugurates NATCO Pharma Division at Dehradun, India|
|2003||Launches oncology division with introduction of flagship brand VEENAT for the treatment of chronic myelogenousleukaemia|